These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 2510679
1. [Value of transesophageal auricular stimulation for evaluating the accessory pathway and effect of treatment in Wolf-Parkinson-White syndrome]. Kieny JR, Kraenner C, Facello A, Roul G, Mossard JM, Bareiss P, Sacrez A. Arch Mal Coeur Vaiss; 1989 Sep; 82(9):1585-93. PubMed ID: 2510679 [Abstract] [Full Text] [Related]
2. [Wolff-Parkinson-White syndrome. Value of transesophageal atrial stimulation coupled with exercise test for the study of anterograde conduction in the accessory pathway]. Cebron JP, Le Marec H, Victor J, Chevallier JC, Borgat C, Godin JF. Arch Mal Coeur Vaiss; 1989 Feb; 82(2):159-66. PubMed ID: 2500076 [Abstract] [Full Text] [Related]
3. [Influence of exercise on the permeability of accessory pathways and supraventricular arrhythmia in Wolff-Parkinson-White syndrome]. Mabo P, Kermarrec A, Gras D, Paillard F, Bédossa M, Daubert C. Arch Mal Coeur Vaiss; 1992 Oct; 85(10):1443-8. PubMed ID: 1297293 [Abstract] [Full Text] [Related]
4. [Effects of oral and injectable flecainide in patients with an accessory atrioventricular pathway]. Fauchier JP, Cosnay P, Rouesnel P, Moquet B, Bonnet P, Scala PJ, Demeyer JF. Arch Mal Coeur Vaiss; 1985 Oct; 78 Spec No():81-90. PubMed ID: 3938264 [Abstract] [Full Text] [Related]
5. [Asymptomatic pre-excitation. Identification of potential risk using transesophageal pacing]. Patruno N, Critelli G, Pulignano G, Urbani P, Villanti P, Reale A. Cardiologia; 1989 Sep; 34(9):777-81. PubMed ID: 2605586 [Abstract] [Full Text] [Related]
6. [Effects of oral sotalol on the conduction of accessory atrioventricular pathways]. Blanc JJ, Boschat J, Ollivier JP, Penther P. Arch Mal Coeur Vaiss; 1985 Jul; 78(7):1097-102. PubMed ID: 3929739 [Abstract] [Full Text] [Related]
7. Effect of atropine and isoproterenol on tachycardia induction in asymptomatic patients with Wolff-Parkinson-White electrocardiographic pattern. Kim YH, Leitch JW, Klein GJ, Yee R, Leather RA. Can J Cardiol; 1992 Sep; 8(7):716-20. PubMed ID: 1422992 [Abstract] [Full Text] [Related]
8. [Outcome of Wolff-Parkinson-White syndrome in children. Transesophageal study of anterograde permeability of the accessory pathway and of atrial vulnerability]. Villain E, Attali T, Iserin L, Aggoun Y, Kachaner J. Arch Mal Coeur Vaiss; 1994 May; 87(5):649-52. PubMed ID: 7857188 [Abstract] [Full Text] [Related]
9. [Oral propranolol in Wolff-Parkinson-White syndrome. Electrophysiological data]. Dolla E, Levy S, Cointe R, Moyal C, Bru P, Rossi P, Gérard R. Arch Mal Coeur Vaiss; 1991 Jul; 84(7):917-21. PubMed ID: 1929709 [Abstract] [Full Text] [Related]
10. Clinical and electrophysiologic characteristics in patients with Wolff-Parkinson-White pattern. Antunes E, da Silva N, Catarino C, Serra J, Galrinho A, Ferreira R, Quininha J, Gracias R, Rato JA. Rev Port Cardiol; 1993 Apr; 12(4):333-6. PubMed ID: 8512728 [Abstract] [Full Text] [Related]
11. [Use of transesophageal left atrial cardiac pacing for assessment of cordarone effectiveness in patients with atrioventricular tachycardia]. Matiushin GV, Shul'man VA, Balog AI, Golovenkin SE, Bezruk AP, Ivanitskiĭ EA, Smirnova OV. Ter Arkh; 1998 Apr; 70(6):47-50. PubMed ID: 9695227 [Abstract] [Full Text] [Related]
12. [Atrial fibrillation in Wolff-Parkinson-White syndrome. Development and therapy]. Duckeck W, Kuck KH. Herz; 1993 Feb; 18(1):60-6. PubMed ID: 8454253 [Abstract] [Full Text] [Related]
14. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. Klein GJ, Bashore TM, Sellers TD, Pritchett EL, Smith WM, Gallagher JJ. N Engl J Med; 1979 Nov 15; 301(20):1080-5. PubMed ID: 492252 [Abstract] [Full Text] [Related]
15. [Electrophysiologic effect of sotalol in supraventricular tachycardias]. Borggrefe M, Breithardt G. Z Kardiol; 1985 Sep 15; 74(9):506-11. PubMed ID: 4060828 [Abstract] [Full Text] [Related]
16. [Wolff-Parkinson-White syndrome. Value of intravenous flecainide for detecting Kent's pathways with short refractory period]. Talard P, Cointe R, Bru P, Moyal C, Lacombe P, Bremondy M, Levy S, Gerard R. Arch Mal Coeur Vaiss; 1990 Apr 15; 83(4):489-92. PubMed ID: 2111669 [Abstract] [Full Text] [Related]
17. [Effect of heart rate on the refractory period of the accessory atrioventricular pathway in Wolff-Parkinson-White syndrome]. Fromer M, Gloor H, Kappenberger L. Schweiz Med Wochenschr; 1985 Nov 02; 115(44):1545-51. PubMed ID: 4081683 [Abstract] [Full Text] [Related]